rs4986791

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_138554.5(TLR4):​c.1196C>T​(p.Thr399Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0613 in 1,613,894 control chromosomes in the GnomAD database, including 3,597 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.049 ( 250 hom., cov: 32)
Exomes 𝑓: 0.063 ( 3347 hom. )

Consequence

TLR4
NM_138554.5 missense

Scores

2
16

Clinical Significance

Benign criteria provided, single submitter U:1B:2O:1

Conservation

PhyloP100: -0.201

Publications

1122 publications found
Variant links:
Genes affected
TLR4 (HGNC:11850): (toll like receptor 4) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0031039119).
BP6
Variant 9-117713324-C-T is Benign according to our data. Variant chr9-117713324-C-T is described in ClinVar as Benign. ClinVar VariationId is 6661.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.105 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TLR4NM_138554.5 linkc.1196C>T p.Thr399Ile missense_variant Exon 3 of 3 ENST00000355622.8 NP_612564.1
TLR4NM_003266.4 linkc.1076C>T p.Thr359Ile missense_variant Exon 4 of 4 NP_003257.1
TLR4NM_138557.3 linkc.596C>T p.Thr199Ile missense_variant Exon 2 of 2 NP_612567.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TLR4ENST00000355622.8 linkc.1196C>T p.Thr399Ile missense_variant Exon 3 of 3 1 NM_138554.5 ENSP00000363089.5
ENSG00000285082ENST00000697666.1 linkc.140+4595C>T intron_variant Intron 3 of 4 ENSP00000513391.1

Frequencies

GnomAD3 genomes
AF:
0.0494
AC:
7511
AN:
152076
Hom.:
250
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0154
Gnomad AMI
AF:
0.0362
Gnomad AMR
AF:
0.0408
Gnomad ASJ
AF:
0.0513
Gnomad EAS
AF:
0.000965
Gnomad SAS
AF:
0.113
Gnomad FIN
AF:
0.0963
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.0642
Gnomad OTH
AF:
0.0451
GnomAD2 exomes
AF:
0.0566
AC:
14176
AN:
250350
AF XY:
0.0602
show subpopulations
Gnomad AFR exome
AF:
0.0140
Gnomad AMR exome
AF:
0.0266
Gnomad ASJ exome
AF:
0.0511
Gnomad EAS exome
AF:
0.000381
Gnomad FIN exome
AF:
0.105
Gnomad NFE exome
AF:
0.0576
Gnomad OTH exome
AF:
0.0576
GnomAD4 exome
AF:
0.0625
AC:
91406
AN:
1461700
Hom.:
3347
Cov.:
32
AF XY:
0.0636
AC XY:
46272
AN XY:
727150
show subpopulations
African (AFR)
AF:
0.0149
AC:
499
AN:
33476
American (AMR)
AF:
0.0282
AC:
1261
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
0.0519
AC:
1355
AN:
26132
East Asian (EAS)
AF:
0.000378
AC:
15
AN:
39674
South Asian (SAS)
AF:
0.105
AC:
9062
AN:
86256
European-Finnish (FIN)
AF:
0.102
AC:
5432
AN:
53372
Middle Eastern (MID)
AF:
0.0473
AC:
273
AN:
5768
European-Non Finnish (NFE)
AF:
0.0626
AC:
69596
AN:
1111952
Other (OTH)
AF:
0.0648
AC:
3913
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
5579
11159
16738
22318
27897
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2564
5128
7692
10256
12820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0493
AC:
7509
AN:
152194
Hom.:
250
Cov.:
32
AF XY:
0.0525
AC XY:
3908
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.0154
AC:
640
AN:
41552
American (AMR)
AF:
0.0407
AC:
622
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.0513
AC:
178
AN:
3468
East Asian (EAS)
AF:
0.000967
AC:
5
AN:
5168
South Asian (SAS)
AF:
0.113
AC:
544
AN:
4824
European-Finnish (FIN)
AF:
0.0963
AC:
1019
AN:
10584
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.0642
AC:
4364
AN:
68004
Other (OTH)
AF:
0.0446
AC:
94
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
357
715
1072
1430
1787
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0542
Hom.:
1077
Bravo
AF:
0.0409
TwinsUK
AF:
0.0510
AC:
189
ALSPAC
AF:
0.0563
AC:
217
ESP6500AA
AF:
0.0166
AC:
73
ESP6500EA
AF:
0.0626
AC:
538
ExAC
AF:
0.0550
AC:
6681
Asia WGS
AF:
0.0640
AC:
221
AN:
3474
EpiCase
AF:
0.0612
EpiControl
AF:
0.0576

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:2Other:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1Other:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
NEI Ophthalmic Genomics Laboratory, National Institutes of Health
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

COPD, severe early onset Uncertain:1
Sep 01, 2023
HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:research

- -

TLR4 POLYMORPHISM Benign:1
Jul 18, 2002
OMIM
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
2.1
DANN
Uncertain
0.97
DEOGEN2
Benign
0.25
.;T;T
Eigen
Benign
-0.97
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.51
T;.;T
MetaRNN
Benign
0.0031
T;T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
1.3
.;L;L
PhyloP100
-0.20
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-2.2
N;.;N
REVEL
Benign
0.016
Sift
Uncertain
0.024
D;.;D
Sift4G
Benign
0.090
T;.;T
Polyphen
0.18
.;B;B
Vest4
0.063
MPC
0.12
ClinPred
0.0079
T
GERP RS
0.43
Varity_R
0.21
gMVP
0.40
Mutation Taster
=83/17
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4986791; hg19: chr9-120475602; COSMIC: COSV62922311; COSMIC: COSV62922311; API